Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Purvis

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cancer|May 15, 1990
Cancer clinical trials. A case for collaborationJ D Purvis
United States Naval Medical Bulletin|October 29, 2010
Report of food-borne streptococcus outbreakJ D PURVIS, G C MORRIS
Cleveland Clinic Journal of Medicine|November 1, 1989
Familial polycythemia veraR L Miller, J D Purvis, J K Weick
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
Vinca alkaloidsB A Chabner, S B Horwitz, N J Clendennin, et al.
Cancer Treatment Reports|January 1, 1981
Phase II evaluation of PALA and AMSA for patients with disseminated malignant melanomaE T Creagan, D L Ahmann, J N Ingle, et al.
Journal of the American Veterinary Medical Association|January 15, 1991
Segmental spinal fixation of a thoracic vertebral fracture in an adult chimpanzeeA Shores, J D Purvis, D Jones, et al.
American Journal of Clinical Oncology|October 1, 1987
Phase II trial of sequential chemotherapy and low-dose radiotherapy in advanced gastric adenocarcinoma. A Southwest Oncology Group Pilot StudyR M Bukowski, A Theodors, J D Purvis, et al.
Ophthalmology|March 1, 1985
Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomasD F Miller, J W Bay, R J Lederman, et al.
Cancer Treatment Reports|July 1, 1984
Aggressive doxorubicin-containing regimen (prednisone, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancerJ Mortimer, R B Livingston, I J Hardesty, et al.
Cancer Chemotherapy and Pharmacology|August 24, 1999
Phase I/pharmacokinetic trial of the novel thioxanthone SR233377 (WIN33377) on a 5-day scheduleJ P Stevenson, D DeMaria, D Reilly, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cancer|May 15, 1990
Cancer clinical trials. A case for collaborationJ D Purvis
United States Naval Medical Bulletin|October 29, 2010
Report of food-borne streptococcus outbreakJ D PURVIS, G C MORRIS
Cleveland Clinic Journal of Medicine|November 1, 1989
Familial polycythemia veraR L Miller, J D Purvis, J K Weick
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
Vinca alkaloidsB A Chabner, S B Horwitz, N J Clendennin, et al.
Cancer Treatment Reports|January 1, 1981
Phase II evaluation of PALA and AMSA for patients with disseminated malignant melanomaE T Creagan, D L Ahmann, J N Ingle, et al.
Journal of the American Veterinary Medical Association|January 15, 1991
Segmental spinal fixation of a thoracic vertebral fracture in an adult chimpanzeeA Shores, J D Purvis, D Jones, et al.
American Journal of Clinical Oncology|October 1, 1987
Phase II trial of sequential chemotherapy and low-dose radiotherapy in advanced gastric adenocarcinoma. A Southwest Oncology Group Pilot StudyR M Bukowski, A Theodors, J D Purvis, et al.
Ophthalmology|March 1, 1985
Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomasD F Miller, J W Bay, R J Lederman, et al.
Cancer Treatment Reports|July 1, 1984
Aggressive doxorubicin-containing regimen (prednisone, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancerJ Mortimer, R B Livingston, I J Hardesty, et al.
Cancer Chemotherapy and Pharmacology|August 24, 1999
Phase I/pharmacokinetic trial of the novel thioxanthone SR233377 (WIN33377) on a 5-day scheduleJ P Stevenson, D DeMaria, D Reilly, et al.
Pageof 2